Pivatto Júnior, F. et al. 2015. Major bleeding risk assessment in atrial fibrillation patients taking vitamin K antagonists. Clinical and Biomedical Research. 35, 2 (jul. 2015). DOI:https://doi.org/10.22491/2357-9730.54273.